We are excited to announce today our partnership with NVIDIA , connecting our G4 Sequencing Platform to NVIDIA Clara
Nov 10, 2021
Cancer-focused genetic testing services firm NeoGenomics, based in Fort Myers, Fla
NeoGenomics: Dave Daly NeoGenomics has appointed Dave Daly to its board of directors, effective Nov
MYERS, FL / ACCESSWIRE / November 10, 2021 / NeoGenomics, Inc
Presenting today are Singular Genomics founder and chief executive officer, Drew Spaventa; and head of finance, Dalen Meeter
MYERS, FL/ ACCESSWIRE/ November 10, 2021/ NeoGenomics, Inc
Spatial Sequencing
Michael Ryskin - Bank of America
Dave Daly-- President and Chief Operating Dave Daly joined our Board of Directors effective November 10, 2021
This directory covers Dave Daly
Thomas joins genomics industry veteran David Daly (former CEO at Thrive Earlier Detection and former CCO at Foundation Medicine) in building a world-class commercial team designed to deliver an View Jason Ryan's email address (j*****@singul***
NeoGenomics has appointed Dave Daly to its board of directors, effective Nov
Prior to Singular Genomics, Mr
Naji, Shawn Carr, Jason Ryan, Darin McDaniel, Sepideh Rogers, Greg Newman, Mike Hager, Mohammad Vatankhah, Mark Lane, Dave Daly, Ron Graham
specializes in cancer genetics testing and information services, providing one of the most comprehensive oncology-focused testing menus in the world for physicians to help them diagnose and treat cancer
2w Report this post More to come! Singular Genomics 7,010 followers
, a leading provider of cancer-focused genetic testing services and View Keith Bullion's email address (k*****@singul***
Director of Sales
Simon works at Singular Genomics as Director Of Electrical Engineering
Mark is based out of San Marcos, California, United States and works in the Biotechnology Research industry
View Daan Witters' email address (d*****@singul***
, a leading provider of cancer-focused genetic testing services and global
Daly currently serves as the President and Chief Operating Officer at Singular Genomics, a novel next generation sequencing and multi-omics technology platform company